Ontvang nu dagelijks onze kooptips!

word abonnee
IEX 25 jaar desktop iconMarkt Monitor

Crucell« Terug naar discussie overzicht

Broadvector Limited

3 Posts
| Omlaag ↓
  1. [verwijderd] 17 februari 2010 19:50
    Nooit wat van gelezen maar staat ineens op lijst licentienemers per dec 2008.

    Broadvector Limited Dec. 2008 PER.C6®
    Adenovirus-vectored product

    Melbourne-based Broadvector Limited (Broadvector) is an Australian biotechnology company that focuses on conditions of the ageing population.

    This demographic is the fastest growing market in society as life expectancies increase and governments are seeking more cost effective treatments. Broadvector's projects have the potential to provide improved health solutions for existing unmet medical needs in this sector.

    Broadvector is developing therapies for the treatment of early stage prostate cancer and aseptic prosthetic loosening (e.g. in hip replacements) - in each case using gene directed enzyme-prodrug therapies ('GDEPT'). GDEPT is a sophisticated site-specific drug delivery system that enables drugs of high potency to be made available to target tissues, without having to circulate through the body first.

    Additionally, the Company's technology platform has a wide-ranging capability in developing vaccines.
    www.broadvector.com.au/irm/content/in...

  2. MeawandMoo1 17 februari 2010 21:22
    quote:

    gocrucellgo schreef:

    Nooit wat van gelezen maar staat ineens op lijst licentienemers per dec 2008.

    Broadvector Limited Dec. 2008 PER.C6®
    Adenovirus-vectored product

    Additionally, the Company's technology platform has a wide-ranging capability in developing vaccines.
    www.broadvector.com.au/irm/content/in...
    HQ Region Melbourne Area, Australia
    Industry: Biotechnology
    Type: Public Company
    Status: Operating
    Company Size: 4 employees
    Website broadvector.com
3 Posts
|Omhoog ↑

Meedoen aan de discussie?

Word nu gratis lid of log in met je emailadres en wachtwoord.